A 438079 hydrochloride 100 mg | 100.00%
TargetMol
A 438079 hydrochloride (A-438079 HCl) is a potent and selective P2X7 receptor antagonist with pIC50 of 6.9.
More Information Supplier PageA 438079 hydrochloride
Search Results
Elacridar 200 mg | 99.15%
TargetMol
Elacridar (GF120918) is an effective BCRP and P-gp (MDR-1) inhibitor.
More Information Supplier PageElacridar
Elacridar 100 mg | 99.15%
TargetMol
Elacridar (GF120918) is an effective BCRP and P-gp (MDR-1) inhibitor.
More Information Supplier PageElacridar
MK-8245 25 mg | Purity Not Available
TargetMol
MK-8245 is a liver-targeting SCD inhibitor for human SCD1 (IC50: 1 nM) and for rat/mouse SCD1 (IC50: 3 nM), with anti-diabetic and anti-dyslipidemic function.
More Information Supplier PageMK-8245
MK-8245 2 mg | Purity Not Available
TargetMol
MK-8245 is a liver-targeting SCD inhibitor for human SCD1 (IC50: 1 nM) and for rat/mouse SCD1 (IC50: 3 nM), with anti-diabetic and anti-dyslipidemic function.
More Information Supplier PageMK-8245
IDO5L 100 mg | 100.00%
TargetMol
IDO5L (INCB024360 analogue) is an effective IDO1 inhibitor(IC50=10 nM).
More Information Supplier PageIDO5L
Gandotinib 100 mg | 99.86%
TargetMol
LY2784544(Gandotinib) is a potent JAK2 inhibitor (IC50: 3 nM), effective in JAK2V617F(Ki: 0.245 nM). The selectivity is higher 8- and 20-fold than JAK1 and JAK3.
More Information Supplier PageGandotinib
Decernotinib 100 mg | 99.64%
TargetMol
Decernotinib(VX-509; VRT-831509) is a potent and selective Janus kinase 3 (JAK3) inhibitor with Ki of 2.5 nM; IC50 is 50-170 nM in cellular assays.
More Information Supplier PageDecernotinib
ZMC1 100 mg | 97.48%
TargetMol
NSC319726, a mutant p53R175 reactivator, suppresses growth of fibroblasts that expresses the p53R175 mutation (IC50 = 8 nM).
More Information Supplier PageZMC1
ZMC1 25 mg | 97.48%
TargetMol
NSC319726, a mutant p53R175 reactivator, suppresses growth of fibroblasts that expresses the p53R175 mutation (IC50 = 8 nM).
More Information Supplier PageZMC1